Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The clinical analgesic efficacy of buprenorphine.

Raffa RB, Haidery M, Huang HM, Kalladeen K, Lockstein DE, Ono H, Shope MJ, Sowunmi OA, Tran JK, Pergolizzi JV Jr.

J Clin Pharm Ther. 2014 Dec;39(6):577-83. doi: 10.1111/jcpt.12196. Epub 2014 Jul 29.

PMID:
25070601
2.

Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.

Koltzenburg M, Pokorny R, Gasser UE, Richarz U.

Pain. 2006 Dec 15;126(1-3):165-74. Epub 2006 Aug 9.

PMID:
16901645
3.

Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.

Kögel B, Christoph T, Strassburger W, Friderichs E.

Eur J Pain. 2005 Oct;9(5):599-611.

PMID:
16139189
4.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
5.

Buprenorphine: new pharmacological aspects.

Cowan A.

Int J Clin Pract Suppl. 2003 Feb;(133):3-8; discussion 23-4. Review.

PMID:
12665117
6.

Efficacy of Full µ-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists - Preclinical and Clinical Evidence.

van Niel JC, Schneider J, Tzschentke TM.

Drug Res (Stuttg). 2016 Nov;66(11):562-570. Epub 2016 Aug 9. Review.

PMID:
27504867
7.

Partial versus full agonists for opioid-mediated analgesia--focus on fentanyl and buprenorphine.

Zuurmond WW, Meert TF, Noorduin H.

Acta Anaesthesiol Belg. 2002;53(3):193-201. Review.

PMID:
12461829
8.

Buprenorphine: considerations for pain management.

Johnson RE, Fudala PJ, Payne R.

J Pain Symptom Manage. 2005 Mar;29(3):297-326. Review.

PMID:
15781180
9.

Buprenorphine--a review of its role in neuropathic pain.

Hans G.

J Opioid Manag. 2007 Jul-Aug;3(4):195-206. Review.

PMID:
17957979
10.

Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine.

Upadhyay J, Anderson J, Baumgartner R, Coimbra A, Schwarz AJ, Pendse G, Wallin D, Nutile L, Bishop J, George E, Elman I, Sunkaraneni S, Maier G, Iyengar S, Evelhoch JL, Bleakman D, Hargreaves R, Becerra L, Borsook D.

Neuroimage. 2012 Feb 15;59(4):3762-73. doi: 10.1016/j.neuroimage.2011.11.034. Epub 2011 Nov 18.

PMID:
22119647
11.

Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor.

Bloms-Funke P, Gillen C, Schuettler AJ, Wnendt S.

Peptides. 2000 Jul;21(7):1141-6.

PMID:
10998549
13.

Switching from high doses of pure μ-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study.

Lundorff L, Sjøgren P, Hansen OB, Jonsson T, Nielsen PR, Christrup L.

J Opioid Manag. 2013 Jul-Aug;9(4):255-62. doi: 10.5055/jom.2013.0166.

PMID:
24353018
14.
15.

Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.

Khroyan TV, Polgar WE, Jiang F, Zaveri NT, Toll L.

J Pharmacol Exp Ther. 2009 Dec;331(3):946-53. doi: 10.1124/jpet.109.156711. Epub 2009 Aug 27.

16.

Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.

Kress HG.

Eur J Pain. 2009 Mar;13(3):219-30. doi: 10.1016/j.ejpain.2008.04.011. Epub 2008 Jun 24. Review.

PMID:
18567516
17.

Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain.

Christoph T, Kögel B, Schiene K, Méen M, De Vry J, Friderichs E.

Eur J Pharmacol. 2005 Jan 10;507(1-3):87-98. Epub 2004 Dec 30.

PMID:
15659298
18.

Transdermal buprenorphine.

Evans HC, Easthope SE.

Drugs. 2003;63(19):1999-2010; discussion 2011-2. Review.

PMID:
12962515
19.

Buprenorphine induces ceiling in respiratory depression but not in analgesia.

Dahan A, Yassen A, Romberg R, Sarton E, Teppema L, Olofsen E, Danhof M.

Br J Anaesth. 2006 May;96(5):627-32. Epub 2006 Mar 17.

PMID:
16547090
20.

Opioid agonist-antagonist drugs in acute and chronic pain states.

Hoskin PJ, Hanks GW.

Drugs. 1991 Mar;41(3):326-44. Review.

PMID:
1711441

Supplemental Content

Support Center